Introduction
Depth of wall invasion and status of lymph node metastasis are the most important factors for estimating outcome after gastrectomy for cancer [1, 2] . The prognosis of patients with superficial gastric cancer and nodenegative gastric cancer is excellent [3, 4] , whereas the survival rate for patients with serosal invasion and lymph node metastasis is not good [5, 6] . In patients with gastric cancer associated with extragastric lymph node metastasis, many patients die of recurrence soon after gastrectomy, but some are alive without recurrence for more than 10 years [7, 8] .
Although many authors have investigated the prognostic factors of gastric cancer [1] [2] [3] [4] [5] [6] [7] [8] 9] , there are few comprehensive studies of the surgical results and prognostic factors in patients with gastric cancer with extragastric lymph node metastasis. In the present study, we investigated prognostic factors in patients with gastric cancer in whom lymph node metastasis was not confined to the perigastric lymph nodes, but reached the extragastric lymph nodes. The clinicopathologic factors influencing the survival after gastrectomy were examined based on survival curves, and the prognostic factors of gastric cancer involving the extragastric lymph nodes were clarified using multivariate analysis.
Patients and methods
Our study population consisted of 121 patients who had undergone radical gastrectomy and extended lymph node dissection (D2, D3) at the First Department of Surgery, Oita Medical University, between June 1982 and October 1998. All patients had histologically confirmed primary adenocarcinoma of the stomach involving extragastric lymph node metastasis (n2, n3). Excluded were patients with tumors invading the adjacent organs, those with liver metastasis, and those with peritoneal dissemination.
Clinicopathologic findings obtained from operation records and pathology reports were the age and sex of the patients; type of gastrectomy; extent of lymph node dissection; location, size, gross type, and histologic type of tumors; depth of wall invasion; presence of lymphatic and vascular invasions; status of lymph node metastasis; stage of disease; and operative curability. These parameters were determined according to the Japanese classification of gastric carcinoma outlined by the Japanese Gastric Cancer Association [10] .
Histologic type was classified into two major categories: well differentiated (including papillary and tubular adenocarcinomas, poorly differentiated medullary carcinoma, and mucinous carcinoma of well differentiated type) and poorly differentiated (including poorly differentiated adenocarcinoma of common type, signet-ring cell carcinoma, and mucinous carcinoma of poorly differentiated type) [11] . Lymphatic and vascular invasions were regarded as negative when the findings were absent or slight (ly0, ly1; v0, v1) and positive when the findings were moderate or marked (ly2, ly3; v2, v3). Operation was regarded as curative when no residual cancer cells were considered to have been left behind.
Status of lymph node metastasis was classified according to the anatomical distribution of positive lymph nodes outlined by the Japanese Gastric Cancer Association (n2, n3) [10] , total number of positive lymph nodes determined by the International Union Against Cancer (UICC) classification (N1, 1-6; N2, 7-15; N3, Ն16) [12] , and level of positive lymph nodes was determined irrespective of tumor location (level II, level III) [13] . Whether extragastric lymph node metastasis was confined to the lymph nodes along the left gastric artery (station no. 7) or to the lymph nodes along the common hepatic artery (station no. 8) was also checked.
The outcome of all patients was examined through a follow-up study, including outpatient visits, telephone contact, and examination of death certificates. The follow-up period for the survivors ranged from 12 to 150 months, with a mean of 67 months and a median of 61 months; only patients who died of gastric cancer were regarded as cases of tumor-related death. Seventy-two patients died of recurrence; in 48 of these patients the pattern of recurrence was identified (local and/or peritoneal recurrence in 34, liver metastasis in 6, bone metastasis in 3, lung metastasis in 2, lymph node metastasis in 2, and esophageal recurrence in 1). The remaining 24 patients died of recurrent gastric cancer, but the pattern of recurrence was not identified. Cumulative survival rates were calculated by the Kaplan-Meier method, and survival curves were tested by the Mantel-Cox method. Multivariate analysis was performed using the Cox proportional hazards model.
Results
The overall 5-year survival rate was 32%, and the 50% survival period was 19 months (Fig. 1 ). Survival after gastrectomy was associated with the type of gastrectomy (distal vs total; P Ͻ 0.05), stage of disease (II, IIIa vs IIIb, IV; P Ͻ 0.01), operative curability (curative vs noncurative; P Ͻ 0.01), tumor size (Ͻ10 cm vs Ն10 cm; P Ͻ 0.01), depth of wall invasion (T1, T2 vs T3; P Ͻ 0.01; within vs beyond muscularis; P Ͻ 0.01), and anatomical distribution of positive lymph nodes (n2 vs n3; P Ͻ 0.05) ( Table 1) . Although the survival was influenced by the number of positive lymph nodes (N1, N2 vs N3), the difference was not significant (P ϭ 0.051). The 5-year survival rates for patients with 1-2 positive nodes (25%), 3-5 positive nodes (48%), 6-15 positive nodes (36%), and Ն16 positive nodes (18%) were not significantly different.
In patients with curative gastrectomy, the 5-year survival rate was 37%, and the 50% survival period was 26 months. Table 2 shows that the survival after curative gastrectomy was associated with the type of gastrectomy (distal vs total; P Ͻ 0.01), stage of disease (II, IIIa vs IIIb, IV; P Ͻ 0.01), tumor size (Ͻ10 cm vs Ն10 cm; P Ͻ 0.01), gross type (localized vs infiltrative; P Ͻ 0.05), and depth of wall invasion (T1, T2 vs T3; P Ͻ 0.01; within vs beyond muscularis; P Ͻ 0.01). Although the survival was influenced by the location of tumors (lower two-thirds vs upper one-third), the difference was not significant (P ϭ 0.052). The anatomical distribution and number and level of positive lymph nodes were not associated with the survival after curative gastrectomy. Factors associated with survival after gastrectomy were a operative curability and b depth of wall invasion. The survival curves show that only curative gastrectomy and serosa-negative tumor brought about a favorable outcome in gastric cancer with extragastric lymph node metastasis. T1, mucosa and submucosa; T2, muscularis and subserosa; T3, serosa Fig. 3 . The factor associated with survival after curative gastrectomy was the depth of wall invasion. The survival curve shows that T1 or T2 tumor brought about a favorable outcome in gastric cancer with extragastric lymph node metastasis Table 3 shows the independent prognostic factors. Analysis based on the 19 factors listed in Table 1 revealed that the factors associated with survival after gastrectomy were operative curability and depth of wall invasion (Fig. 2) . However, analysis based on the 18 factors listed in Table 2 revealed that the factor associated with the survival after curative gastrectomy was depth of wall invasion (Fig. 3) .
Discussion
The results of the present study indicated that the prognosis of patients with gastric cancer with extragastric lymph node metastasis was independently influenced by operative curability and depth of wall invasion, and, when gastrectomy was curative, prognosis was determined by the depth of wall invasion. Therefore, the only candidates for long-term survival are those patients without serosal invasion (T1, T2) who are treated by curative radical gastrectomy.
Several authors have emphasized that curative resection is essential for the treatment of patients with gastric cancer, and that curability, based on the operative and pathological findings, is important for evaluating longterm survival after gastrectomy [9] . In patients with extensive lymph node metastasis, however, curative resection can be achieved only by radical gastrectomy and T1, Mucosa and submucosa; T2, muscularis and subserosa; T3, serosa extended lymph node dissection. The procedures have been advocated by some Japanese gastric surgeons [14, 15] , although several other groups have emphasized that radical gastectomy with extended lymph node dissection is associated with high morbidity and mortality [16] [17] [18] . The depth of wall invasion is one of the most important prognostic factors in gastric cancer [1, 2, 6, 8] . The present study confirmed that the depth of wall invasion was a useful parameter for predicting the survival of patients with gastric cancer involving extragastric lymph nodes. Some authors have clarified that not only the presence or absence of serosal invasion but also the width of serosal invasion is linked to survival after gastrectomy [5] . In our series, serosal invasion was absent in 50 (41%) of the 121 patients and in 43 (41%) of the 104 patients with curative gastrectomy. Thus, approximately 40% of patients with extragastric lymph node metastasis are candidates for survivors.
In the present study, the 5-year survival rate after distal gastrectomy was significantly higher than that after total gastrectomy. This confusing finding was considered to have resulted from the fact that more tumors located in the upper one-third of the stomach and more tumors larger than 10 cm in size had been treated by total gastrectomy. Previous reports on a randomized clinical trial show that subtotal gastrectomy is equivalent to total gastrectomy in terms of 5-year survival, but is superior to total gastrectomy in terms of the patients' nutritional state and quality of life [19, 20] .
The level and number of lymph node metastases is another important prognostic indicator of gastric cancer [7] [8] [9] [10] 21] . Table 4 lists the 5-year survival rates of patients with gastric cancer with extragastric lymph node metastasis and shows that the level of lymph node metastasis is associated with survival [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] . The 5-year survival rates of n2 and n3 cases in our series were in accordance with those in the literature, and the 5-year survival rate was significantly different between the n2 and n3 cases in most series, including ours (39% vs 17%; P Ͻ 0.05). In patients with curative gastrectomy, however, the 5-year survival rate of n3 cases was as high as that of n2 cases. The 5-year survival rate for patients in whom extragastric lymph node metastasis was confined to the nodes along the left gastric artery (station no. 7; 45%, n ϭ 20) or to the lymph nodes along the common hepatic artery (station no. 8; 33%, n ϭ 15) was not significantly different from that in patients with positive lymph nodes classified as "others" (30%; 32%) ( Table  1) .
The aim of this study was to clarify the surgical results in patients with gastric cancer with extragastric lymph node metastasis. Therefore, we reviewed the Englishlanguage literature in which the survival rate of patients with extragastric lymph node metastasis was examined (n2 and n3 in the Japanese classification). Because recent Western studies, such as those by Roder [32] , Manzoni [33] , and Karpeh [34] , depend on the old TNM classification (N1, within 3 cm of the primary tumor; N2, 3 cm beyond the primary tumor), whether lymph node metastasis is perigastric or extragastric cannot be determined in these studies. Accordingly, because of this difference in lymph node classification, we have included only reports from Japan, Korea, and Taipei in our literature survey (Table 4) .
Whether extended lymph node dissection improves the survival of patients with gastric cancer is still controversial [35] [36] [37] . We cannot comment on this problem in regard to our study, because our prognostic analysis was retrospective and historical, and operative strategy and the stage-migration phenomenon are also problems that need to be addressed in assessments of the utility of radical lymph node dissection [38, 39] . A prospective, randomized clinical trial should be able to clarify whether D3 gastrectomy is superior to D2 gastrectomy in patients with extragastric lymph node metastasis.
In conclusion, the operative curability and depth of wall invasion were found to be the most significant factors independently associated with survival time after operation for gastric cancer with extragastric lymph node metastasis. Patients with noncurative gastrectomy or those with serosal invasion frequently died of recur- 
